Evan Y. Yu, MD, Fred Hutchinson Cancer Research Center
Articles
Optimizing Use of PSMA PET Imaging and PSADT in Prostate Cancer
Alicia Morgans, MD, MPH;Matthew R. Smith, MD, PhD, Massachusetts General Hospital Cancer Center;Sandy Srinivas, MBBS, Stanford Cancer Center;Scott T. Tagawa, MD, MS, FACP, Weill Cornell Medicine;Evan Y. Yu, MD, Fred Hutchinson Cancer Research Center
March 30th 2022Shared insight on the respective roles of PSMA-PET imaging and PSA doubling time in the current prostate cancer treatment paradigm.
Read More
Overview of Improvements in Prostate Cancer Management
Alicia Morgans, MD, MPH;Matthew R. Smith, MD, PhD, Massachusetts General Hospital Cancer Center;Sandy Srinivas, MBBS, Stanford Cancer Center;Scott T. Tagawa, MD, MS, FACP, Weill Cornell Medicine;Evan Y. Yu, MD, Fred Hutchinson Cancer Research Center
March 30th 2022Broad discussion on the evolution of care in prostate cancer from both the therapeutic and imaging standpoints.
Read More
Latest Updated Articles
Published: September 27th 2024 | Updated: October 3rd 2024
Phase 1 trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients with DLL3 Positive Tumors: Patients with LCNEC
Published: May 27th 2024 | Updated: September 13th 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma
Published: August 22nd 2024 | Updated: August 29th 2024
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Published: August 6th 2024 | Updated: August 19th 2024
Long-term Follow-up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer: A Prespecified Subgroup Analysis From the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
